• Share
  • Email
  • Print
Photo Not Available

Tucker A. Idol

Associate
+1.919.743.7353
Fax +1.919.743.7358
Tucker Idol is an associate at the firm’s Raleigh office. He is a member of the corporate/M&A practice group, where he advises high-growth and mature clients on all stages of their business life cycle. From protecting their early IP and attracting debt and equity investors to navigating complex acquisitions and high-multiple exits, Mr. Idol helps clients understand how legal risks impact their operations and designs cost-effective strategies to mitigate these risks while advancing their business goals.

Professional Background

Mr. Idol began his career as a corporate attorney in the Los Angeles office of an international law firm, focusing on international asset finance and merger and acquisition transactions. Before joining K&L Gates, he advised emerging growth and venture-backed companies at a full-service business law firm in the Research Triangle region of North Carolina.

Speaking Engagements

  • UNC Kenan-Flagler Business School EMBA SoftLaunch Program, Legal Advisor, 2017 - 2019
  • “Legal Issues for New Companies,” Vernon Malone College & Career Academy, Raleigh, NC
  • “So You Want to Work for a Start-Up Company,” Momentum Learning, Raleigh, NC
M&A:
  • Represented Anthem, Inc. as purchaser in its $54bn public merger with Cigna Corporation to form nation’s largest health insurance provider.
  • Represented Omnicare, Inc. as seller in $10.1bn public merger with CVS Health Corp.
  • Represented venture capital firm in connection with transfer of California limited liability company membership interests to Maltese holding company.
  • Represented entertainment and live-event ticketing company in sale to NY-based private equity group.
  • Represented NC-based 3D sound engineering company in sale to Valve Corporation.
  • Represented provider of advertising and search engine optimization services in $45m+ sale to competitor.
  • Represented Indiana-based auto and mechanical parts manufacturer and distributor in sale to portfolio company of French private equity group.
  • Represented purchaser in asset sale involving novel epinephrine delivery technology conditioned upon complex equity fundraising requirements.
  • Represented court data aggregation provider in sale to competitor.
Venture Finance:
  • Represented CRISPR technology company in $19m Series B preferred stock financing led by California-based venture capital firm.
  • Represented a privately held AgBio company in multiple convertible preferred stock and convertible debt financings to venture capital firms, aggregating over $30 million.
  • Represented fluid resuscitation medical device company in preferred stock and convertible debt financings totaling $10m+.
  • Represented producer of nanoparticle-based imaging technique for treatment of epilepsy in sale of $7m+ of preferred stock to Canadian pension fund.
  • Represented consumer products company in sale of $6m+ in preferred stock.
  • Represented cranial neurosurgical medical device company in successive rounds of convertible note and preferred stock financings.
  • Represented for-profit education provider in sale of $3m+ of preferred stock.
  • Represented a privately held food company in multiple convertible debt, non-convertible debt, and equity financings, aggregating over $5 million.
  • Represented stem cell therapy companies in aggregate sale of $10m in preferred stock to Chinese investment company.
  • Represented developer of nucleic acid delivery platform in sale of $5m in preferred stock to Chinese investment company.
  • Represented manufacturer of cutting-edge semiconductor components in distribution agreement and subsequent equity financing.
  • Represented multiple angel networks (including several university-affiliated angel networks) in connection with investments into emerging growth companies.
Asset Finance & Banking
  • Represented international commercial aircraft leasing company in connection with numerous sale, leaseback, and financing transactions ranging in value from $150m to $280m in partnership with private and sovereign-backed airlines in Southeast Asia, the Middle East, and India.
  • Represented a mid-market private equity group in the multi-tranche leveraged purchase of a large medical services network via reverse triangular merger.
  • Represented borrower in refinancing of a $1XXm term and revolving credit facility supporting Native American gaming operations in Southern California.
  • Represented pro bono lending arm of large global bank in $14m financing for micro-lending platform.